OncoTherapy Science Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.8%.

Top 17 shareholders own 14.84% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
4.72%	Yusuke Nakamura	12,511,000	JP¥500.4m	0%	no data
2.21%	Shuichi Nakatsuru	5,850,000	JP¥234.0m	0%	no data
1.49%	Yoichi Furukawa	3,943,000	JP¥157.7m	0%	no data
1.17%	Central Tanshi Co., Ltd., Asset Management Arm	3,099,600	JP¥124.0m	0%	0.36%
0.94%	Hirofumi Arakawa	2,487,400	JP¥99.5m	0%	no data
0.84%	Japan Securities Finance Co. Ltd., Asset Management Arm	2,225,100	JP¥89.0m	0%	0.01%
0.75%	Long Corridor Asset Management Limited	2,000,000	JP¥80.0m	-75.6%	0.61%
0.59%	Matsui Securities Co. Ltd., Asset Management Arm	1,570,300	JP¥62.8m	0%	0.27%
0.42%	SBI Holdings Inc., Asset Management Arm	1,114,211	JP¥44.6m	0%	0.02%
0.38%	Katsumi Suzuki	1,000,000	JP¥40.0m	0%	no data
0.37%	Kazuko Kitamura	978,000	JP¥39.1m	0%	no data
0.32%	Hiroshi Takeuchi	850,000	JP¥34.0m	0%	no data
0.31%	Takashi Maruta	828,000	JP¥33.1m	0%	no data
0.3%	Koji Toyooka	783,900	JP¥31.4m	0%	no data
0.019%	Yuka Yamane	50,000	JP¥2.0m	0%	no data
0.012%	Miyako Takagi	31,000	JP¥1.2m	0%	no data
0.0003%	Daiwa Asset Management Co., Ltd.	800	JP¥31.8k	0%	no data